查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611969

乙醯異羥肟酸市場：按配方、分銷管道和應用分類 - 2025-2030 年全球預測

Acetohydroxamic Acid Market by Formulation (Liquid, Tablets/Capsules), Distribution Channel (Hospital Pharmacies, Online Pharmacies), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年乙醯氧肟酸市值為5.5449億美元，預計2024年將達到5.8926億美元，複合年成長率為6.39%，到2030年將達到8.5562億美元。

乙醯羥肟酸 (AHA) 是一種主要用於藥用的化合物，特別是用於治療尿素分解菌引起的尿道感染。其抑制尿素酶酶活性的獨特能力對於治療對傳統抗生素抗藥性的感染疾病至關重要。對 AHA 的需求是由抗生素抗藥性細菌感染疾病的流行以及醫學和獸醫領域對替代治療方法的需求所推動的。該化合物也被應用於研究酶活性和代謝異常的研究環境。最終用途包括醫院、診所、實驗室、製藥廠等。市場成長主要是由於對新型抗生素的需求不斷增加以及對尿素酶抑制劑研究的興趣不斷增加所推動的。醫療支出不斷成長的新興國家市場拓展潛力巨大。為了利用這些機會，相關人員應專注於簡化供應鏈並與醫療機構合作。然而，市場面臨嚴格的法律規範、與 AHA 相關的潛在副作用以及現有抗生素的競爭等挑戰。需要繼續研究安全性和有效性概況以消除這些限制。創新研究和開發工作的重點是開發更多可溶性和生物利用度的製劑，將 AHA 的範圍擴大到細菌感染疾病之外，並探索與其他藥物的協同效應組合。隨著醫療保健產業不斷發展以對抗抗生素抗藥性，AHA 市場的性質是動態的，要求相關人員靈活應對新的科學發現和監管變化。此外，透過投資教育工作來幫助人們了解 AHA 的好處，並進行市場研究來客製化我們的產品，以有效滿足特定地區的醫療需求，公司可能會受益。

主要市場統計
基準年[2023] 55449萬美元
預計年份 [2024] 5.8926 億美元
預測年份 [2030] 85562萬美元
複合年成長率（%） 6.39%

市場動態：快速發展的乙醯異羥肟酸市場的關鍵市場洞察

乙醯異羥肟酸市場正在因供需的動態相互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 越來越多使用乙醯氧肟酸治療尿素循環障礙
    • 採用乙醯異羥肟酸作為長效肥料添加劑
  • 市場限制因素
    • 原料供應有限且替代品供應有限
  • 市場機會
    • 基於乙醯異羥肟酸的藥物的快速核准流程
    • 乙醯異羥肟酸生產技術進展
  • 市場挑戰
    • 與乙醯異羥肟酸相關的副作用和環境影響

波特五力：引領乙醯氧肟酸市場的策略工具

波特的五力框架是了解乙醯氧肟酸市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對乙醯異羥肟酸市場的外部影響

外部宏觀環境因素對乙醯氧肟酸市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解乙醯異羥肟酸市場競爭狀況

對乙醯異羥肟酸市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣乙醯異羥肟酸市場供應商的績效評估

FPNV定位矩陣是評估乙醯氧肟酸市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製乙醯氧肟酸市場的成功之路

乙醯異羥肟酸市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加乙醯氧肟酸在尿素循環障礙治療的使用
      • 採用乙醯異羥肟酸作為永續肥料添加劑
    • 抑制因素
      • 原料可得性有限且替代品可得性有限
    • 機會
      • 乙醯異羥肟酸藥物的快速核准流程
      • 乙醯異羥肟酸生產技術進展
    • 任務
      • 與乙醯異羥肟酸相關的副作用和環境影響
  • 市場區隔分析
    • 劑型：錠劑和膠囊是合適的，因為它們易於運輸、儲存，並且可以精確控制劑量。
    • 應用：在醫療領域治療尿道感染採用率較高
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章乙醯異羥肟酸市場（依配方）

  • 液體
  • 錠劑/膠囊

第7章乙醯異羥肟酸市場：按分銷管道

  • 醫院藥房
  • 網路藥房

第8章乙醯異羥肟酸市場：依應用分類

  • 產業
  • 藥品

第9章 北美和南美乙醯異羥肟酸市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區乙醯異羥肟酸市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲乙醯異羥肟酸市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 默克宣布大規模擴張韓國生物加工業務
  • 戰略分析和建議

公司名單

  • BLD Pharmatech Co., Limited
  • Cayman Chemical
  • Hangzhou Dayangchem Co. Ltd.
  • Henan Tianfu Chemical Co., Ltd.
  • Merck KGaA
  • Mission Pharmacal Company
  • Oakwood Chemical
  • Otto Chemie Pvt. Ltd.
  • Santa Cruz Biotechnology
  • Spectrum Chemical Manufacturing Corp.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
Product Code: MRR-CD5A9334DAA6

The Acetohydroxamic Acid Market was valued at USD 554.49 million in 2023, expected to reach USD 589.26 million in 2024, and is projected to grow at a CAGR of 6.39%, to USD 855.62 million by 2030.

Acetohydroxamic acid (AHA) is a chemical compound primarily used as a pharmaceutical agent, especially in the treatment of urinary tract infections caused by urea-splitting bacteria. Its unique capacity to inhibit urease enzyme activity makes it vital for managing infections that are resistant to traditional antibiotics. The necessity for AHA arises from the growing prevalence of antibiotic-resistant bacterial infections and the need for alternative treatment methods in both the medical and veterinary fields. This compound also finds its application in research settings, where it is used to study enzymatic activities and metabolic disorders. The end-use includes hospitals, clinics, research laboratories, and pharmaceutical manufacturing facilities. The market's growth is predominantly driven by the increased demand for novel antibiotics and a heightened focus on research into urease inhibitors. Emerging economies with rising healthcare expenditures present a significant potential for market expansion. To tap into these opportunities, stakeholders should focus on enhancing supply chain efficiency and forging partnerships with healthcare institutions. However, the market faces challenges like stringent regulatory frameworks, potential side effects associated with AHA, and competition from already established antibiotics. Lifting these limitations requires continuous research into safety and efficacy profiles. Innovation and research could be directed towards developing more soluble and bioavailable formulations, widening AHA's applicability beyond bacterial infections, and exploring synergistic combinations with other pharmaceutical agents. As the healthcare sector constantly evolves to combat antibiotic resistance, the nature of the AHA market is dynamic, requiring stakeholders to agilely adapt to new scientific findings and regulatory changes. Furthermore, businesses could benefit by investing in educational initiatives to promote the understanding of AHA's advantages and by conducting market studies to tailor products to meet specific regional healthcare needs effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 554.49 million
Estimated Year [2024] USD 589.26 million
Forecast Year [2030] USD 855.62 million
CAGR (%) 6.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acetohydroxamic Acid Market

The Acetohydroxamic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of acetohydroxamic acid to treat urea cycle disorders
    • Adoption of acetohydroxamic acid as a long-acting fertilizer additive
  • Market Restraints
    • Limited availability of raw materials and availability of alternatives
  • Market Opportunities
    • Expedited approval processes for acetohydroxamic acid-based drugs
    • Advancements in production technologies for acetohydroxamic acid
  • Market Challenges
    • Side effects and environmental impacts associated with acetohydroxamic acid

Porter's Five Forces: A Strategic Tool for Navigating the Acetohydroxamic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acetohydroxamic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Acetohydroxamic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acetohydroxamic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Acetohydroxamic Acid Market

A detailed market share analysis in the Acetohydroxamic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acetohydroxamic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acetohydroxamic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Acetohydroxamic Acid Market

A strategic analysis of the Acetohydroxamic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acetohydroxamic Acid Market, highlighting leading vendors and their innovative profiles. These include BLD Pharmatech Co., Limited, Cayman Chemical, Hangzhou Dayangchem Co. Ltd., Henan Tianfu Chemical Co., Ltd., Merck KGaA, Mission Pharmacal Company, Oakwood Chemical, Otto Chemie Pvt. Ltd., Santa Cruz Biotechnology, Spectrum Chemical Manufacturing Corp., Thermo Fisher Scientific Inc., and Tokyo Chemical Industry Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acetohydroxamic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Formulation, market is studied across Liquid and Tablets/Capsules.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Online Pharmacies.
  • Based on Application, market is studied across Industrial and Medical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of acetohydroxamic acid to treat urea cycle disorders
      • 5.1.1.2. Adoption of acetohydroxamic acid as a long-acting fertilizer additive
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of raw materials and availability of alternatives
    • 5.1.3. Opportunities
      • 5.1.3.1. Expedited approval processes for acetohydroxamic acid-based drugs
      • 5.1.3.2. Advancements in production technologies for acetohydroxamic acid
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects and environmental impacts associated with acetohydroxamic acid
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Suitability of tablets and capsules formulations owing to their easy-to-transport, store, and precise dosage control
    • 5.2.2. Application: High adoption in medical contexts for treatment of urinary tract infections
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Acetohydroxamic Acid Market, by Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Tablets/Capsules

7. Acetohydroxamic Acid Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies

8. Acetohydroxamic Acid Market, by Application

  • 8.1. Introduction
  • 8.2. Industrial
  • 8.3. Medical

9. Americas Acetohydroxamic Acid Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Acetohydroxamic Acid Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Acetohydroxamic Acid Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Merck KGaA Announces Major Bioprocessing Expansion in South Korea
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BLD Pharmatech Co., Limited
  • 2. Cayman Chemical
  • 3. Hangzhou Dayangchem Co. Ltd.
  • 4. Henan Tianfu Chemical Co., Ltd.
  • 5. Merck KGaA
  • 6. Mission Pharmacal Company
  • 7. Oakwood Chemical
  • 8. Otto Chemie Pvt. Ltd.
  • 9. Santa Cruz Biotechnology
  • 10. Spectrum Chemical Manufacturing Corp.
  • 11. Thermo Fisher Scientific Inc.
  • 12. Tokyo Chemical Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ACETOHYDROXAMIC ACID MARKET RESEARCH PROCESS
  • FIGURE 2. ACETOHYDROXAMIC ACID MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ACETOHYDROXAMIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ACETOHYDROXAMIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ACETOHYDROXAMIC ACID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ACETOHYDROXAMIC ACID MARKET DYNAMICS
  • TABLE 7. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ACETOHYDROXAMIC ACID MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ACETOHYDROXAMIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM ACETOHYDROXAMIC ACID MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM ACETOHYDROXAMIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ACETOHYDROXAMIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. ACETOHYDROXAMIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. ACETOHYDROXAMIC ACID MARKET, FPNV POSITIONING MATRIX, 2023